Stronger controls proposed on drug precursors in the Single Market and at the EU borders through Customs

The European Commission seeks to close loopholes in current legislation on drug precursors - legal chemicals contained in a wide range of products, including pharmaceuticals, perfumes and plastics, but which can also be illegally diverted to produce narcotics. It is proposed to reinforce the controls on specific chemicals, both within the Single Market and at the EU borders through Customs.

Read more …

The Commission seeks safer, more effective and innovative medical devices

The European Commission proposed two Regulations that aim to ensure that patients, consumers and healthcare professionals can reap the benefits of safe, effective and innovative medical devices. The medical device sector is highly innovative, particularly in Europe and has an estimated market value of around €95 billions.

Read more …

One out three European citizens is exposed to harmful air pollutants

A report published by the European Environment Agency (EEA) shows that many parts of Europe have persistent problems with outdoor concentrations of PM and ground level ozone. Overall, almost a third of Europe's city dwellers are exposed to excessive concentrations of airborne particulate matter (PM).

Read more …

Public consultation launched on 54 potential Substances of Very High Concern

The European Chemicals Agency (ECHA) opened a public consultation in order to gather views with regard to 54 potential Substances of Very High Concern. 37 substances were proposed by the European Commission. Austria, Germany, the Netherlands, Poland, Slovakia, Sweden and the United Kingdom have also put forward proposals for the identification of 17 substances.

Read more …

EU-funded researchers seek better diagnosis of pneumonia

Researchers from small and medium-sized enterprises (SMEs), universities and hospitals across Ireland, France, Finland and the United Kingdom work in a new project aimed at finding a test that would reduce the diagnosis time of respiratory tract infections from days to hours, so that the appropriate treatments can be administered as early as possible.

Read more …

A report reveals a general decrease in the EU in dietary exposure to dioxins in the food chain

The report published by the European Food Safety Authority (EFSA) shows a general decrease in dietary exposure to dioxins and dioxin-like PCBs, comparing the period 2008-2010 with 2002-2004, of at least 16% and up to 79% for the general population. These toxic substances may cause cancer over time.

Read more …

Useful information for protecting EU citizens health from ground-level ozone this summer presented by EEA

The European Environment Agency (EEA) presents some useful information to avoid harmful ozone pollution this summer. According to the agency, high summer temperatures combined with air pollution can cause ground-level ozone to form, which has serious effects on health, especially for older people or children, or those with asthma and other breathing problems.

Read more …

Public consultation launched on prevention and control of gastroenteritis outbreaks in schools and childcare facilities

The European Center for Disease Prevention and Control (ECDC) launched a public consultation to the technical report “Prevention of norovirus infection in schools and childcare facilities”. The ECDC is seeking views from the scientific community and stakeholders on the prevention and control of gastroenteritis outbreaks in schools and child care facilities.

Read more …

EU policies have improved air quality in harbours

Scientists at the European Commission's Joint Research Centre measured key air quality parameters in Mediterranean harbours. The measures show that sulphur dioxide emissions from shipping have sharply decreased in EU ports thanks to EU policies.

Read more …

The European Medicines Agency steps up the debate on open access to clinical trial data

The European Medicines Agency (EMA) has announced its plans to carry out a proactive publication of data related to clinical trials to allow interested parties full access to these data sets. However, before releasing this information it is necessary to address some political and practical issues. For that purpose the EMA is organising a workshop to be held on November 22.

Read more …